DEF 14A: Hyperfine, Inc. Sets Date for 2024 Annual Stockholders Meeting, Outlines Key Proposals

Hyperfine, Inc. announces its 2024 annual meeting of stockholders to be held virtually on June 11, 2024, featuring proposals for director elections, auditor ratification, and a sunset amendment to the certificate of incorporation.

Summary

• Hyperfine, Inc. will hold its 2024 annual meeting of stockholders virtually on June 11, 2024, at 11:00 a.m. Eastern Time.
• Stockholders of record as of April 15, 2024, are eligible to vote.
• The meeting will address the election of six directors, ratification of Grant Thornton LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2024, and approval of a sunset amendment to the certificate of incorporation.
• The sunset amendment proposes the automatic conversion of Class B common stock to Class A common stock on December 22, 2028.
• The board of directors recommends voting in favor of all proposals.
• The company has posted strong revenue growth, gross margin improvement, and cash burn reduction.

Sentiment

Score: 7

Explanation: The document presents a balanced view, highlighting both progress and future plans while acknowledging potential risks. The tone is generally positive, reflecting confidence in the company's direction.

Positives

• The company received FDA clearance and launched two AI-powered software upgrades to improve Swoop system image quality and ease of use.
• The company has posted strong revenue growth, gross margin improvement, and cash burn reduction.
• The company has exercised strong spending discipline without compromising investments in its three strategic pillars: Innovation, Clinical Evidence and Commercialization.
• The company has executed its financial plans to extend its cash runway.

Risks

• The document contains forward-looking statements that are subject to risks, uncertainties, and assumptions.
• Important factors that could cause actual results to differ materially from those indicated by such forward-looking statements include, among others, those set forth under the heading Risk Factors contained in our Annual Report on Form 10-K for the year ended December 31, 2023 filed with the Securities and Exchange Commission, as well as any updates to those risk factors filed from time to time in our periodic and current reports.

Future Outlook

The company's future performance and its ability to implement its strategy are subject to risks, uncertainties and assumptions.

Management Comments

• Maria Sainz, President and Chief Executive Officer: 'I am pleased with the significant progress we have made since last years annual meeting of stockholders...'
• Maria Sainz, President and Chief Executive Officer: 'We have posted strong revenue growth, gross margin improvement, and cash burn reduction.'

Industry Context

Hyperfine operates in the medical device industry, specifically focusing on ultra-low field magnetic resonance imaging (MRI) technology. The company's progress in obtaining regulatory clearances and expanding its commercial presence reflects its efforts to compete in this market.

Corporate Governance

Related Party Transactions

• The company occupies office space leased from 4Catalyzer Corporation, a related party.
• Legacy Hyperfine and Liminal each entered into a Master Services Agreement with 4Catalyzer effective as of July 7, 2021 pursuant to which Legacy Hyperfine and Liminal may engage 4Catalyzer to provide services such as general administration, facilities, information technology, financing, legal, human resources and other services, through future statements of work and under terms and conditions to be determined by the parties with respect to any services to be provided.
• Legacy Hyperfine and Liminal have entered into Technology and Services Exchange Agreements (each, a TSEA and collectively, the TSEA) with other participant companies controlled by the Rothbergs.

Stakeholder Impact

• Approval of the sunset amendment could impact shareholders by aligning voting rights with economic interests.
• The election of directors will determine the leadership and strategic direction of the company, affecting all stakeholders.
• The ratification of the independent auditor ensures financial oversight and transparency.

Next Steps

• Stockholders are encouraged to vote by proxy before the annual meeting.
• The company will announce preliminary voting results at the annual meeting and publish final results in a Current Report on Form 8-K.

Key Dates

Keywords

annual meeting, proxy statement, directors, stockholders, sunset amendment, Grant Thornton, Class B common stock, Hyperfine